SQI Diagnostics Inc V.SQD.H

Technology Scientific & Technical Instruments

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > 10 Rapid Tests Ready for Approval By Canada Health

<< Previous

Bullboard Posts

Next >>

Comment by barryt34on Oct 10, 2020 3:07pm

69 Views

Post# 31701219

RE:RE:10 Rapid Tests Ready for Approval By Canada Health

I have a feeling Canadian hospitals will buy Sqi's labs, at 1 million a pop. This could be huge And when the labs are in each hospital then it's time to make the real money. Lung transplants and covid is only the beginning. They could expand into different fields. 1,200 hospitals

In total, there were over 1,200 hospitals in Canada as of 2019. Hospital expenditures per capita appear to be highest in less populated territories.Sep 15, 2020

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide